Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/30280
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | TERWEL, Dick | - |
dc.contributor.author | DEWACHTER, Ilse | - |
dc.contributor.author | Van Leuven, Fred | - |
dc.date.accessioned | 2020-01-10T09:37:49Z | - |
dc.date.available | 2020-01-10T09:37:49Z | - |
dc.date.issued | 2002 | - |
dc.date.submitted | 2020-01-09T12:22:05Z | - |
dc.identifier.citation | Neuromolecular medicine, 2 (2) , p. 151-65 -165 | - |
dc.identifier.uri | http://hdl.handle.net/1942/30280 | - |
dc.description.abstract | The molecular causes and the genetic and environmental modifying factors of the sporadic form of Alzheimer's disease (AD) remain elusive. Extrapolating from the known mutations that cause the rare familial forms and from the typical post-mortem pathological lesions in all AD patients--e.g., amyloid plaques and neurofibrillary tangles (NFTs)-the evident molecular candidates are amyloid precursor protein (APP), presenilin, and tau protein. To include ApoE4 as the only certain genetic modifier known leaves us to face the challenge of implementing these very different molecules into an evident pathological partnership. In more than one respect, the proposition of disturbed axonal transport appears attractive with more details becoming available on APP processing and microtubular transport and also of the pathology in the model systems--e.g., transgenic mice expressing APP or protein tau. Conversely, the resistance of APP-transgenic mice with full-blown amyloid pathology to also develop tau-related neurofibrillar pathology is a major challenge for this hypothesis. From the most relevant data discussed here, we conclude that the postulate of disturbed axonal transport as the primary event in AD is difficult to defend. On the other hand, failing axonal transport appears to be of major importance in the later stages in AD, by further compromising tau protein, APP metabolism, and synaptic functioning. Protein tau may thus be the central "executer" in the chain of events leading from amyloid neurotoxicity to tau hyperphosphorylation, microtubular destabilization, disturbed axonal transport, and synaptic failure to neurodegeneration. In order to identify normal physiological processes and novel pathological targets, definition is needed--in molecular detail--of the complex mechanisms involved. | - |
dc.description.sponsorship | This investigation was supported by Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWOVlaanderen); the EEC-5th Framework Program; the Rooms-Fund; the Janssen Research Foundation; the KULeuven GOA-Research Fund and KULeuven R&D; the Institute voor Aanmoediging van Wetenschappelijk en Technisch Onderzoek (IWT). Ilse Dewachter is a post-doctoral fellow of FWOVlaanderen and Dick Terwel is a post-doctoral fellow of IWT. | - |
dc.language.iso | en | - |
dc.publisher | Humana Press Inc | - |
dc.rights | 2002 Humana Press Inc. All rights of any nature whatsoever reserved. | - |
dc.subject.other | axonal transport | - |
dc.subject.other | Alzheimer’s disease | - |
dc.subject.other | transgenic mice | - |
dc.subject.other | protein tau | - |
dc.subject.other | GSK-3β | - |
dc.subject.other | microtubules | - |
dc.subject.other | amyloid | - |
dc.title | Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 165 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 151-65 | - |
dc.identifier.volume | 2 | - |
local.bibliographicCitation.jcat | A1 | - |
local.publisher.place | 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.source.type | Article | - |
dc.identifier.doi | 10.1385/NMM:2:2:151 | - |
dc.identifier.pmid | 12428809 | - |
dc.identifier.isi | 000178982100005 | - |
dc.identifier.eissn | - | |
local.provider.type | PubMed | - |
local.uhasselt.uhpub | no | - |
item.fullcitation | TERWEL, Dick; DEWACHTER, Ilse & Van Leuven, Fred (2002) Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. In: Neuromolecular medicine, 2 (2) , p. 151-65 -165. | - |
item.fulltext | With Fulltext | - |
item.contributor | TERWEL, Dick | - |
item.contributor | DEWACHTER, Ilse | - |
item.contributor | Van Leuven, Fred | - |
item.accessRights | Restricted Access | - |
crisitem.journal.issn | 1535-1084 | - |
crisitem.journal.eissn | 1559-1174 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Terwel2002_Article_AxonalTransportTauProteinAndNe.pdf Restricted Access | Published version | 363.63 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
121
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
114
checked on Sep 27, 2024
Page view(s)
38
checked on Sep 7, 2022
Download(s)
6
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.